Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia.
Open Access
- 1 March 1991
- journal article
- clinical trial
- Published by Wiley
- Vol. 31 (3) , 295-304
- https://doi.org/10.1111/j.1365-2125.1991.tb05533.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Strategy for Measuring the Therapeutic Properties of New Antiparkinsonian Drugs, such as + PHNO, in Patients with On-Off FluctuationsClinical Neuropharmacology, 1989
- BRINGING GAIT ANALYSIS OUT OF THE LABORATORY AND INTO THE CLINICAge and Ageing, 1988
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- Lisuride in parkinsonismNeurology, 1981
- Assessment of drugs in schizophrenia. Asessment of drug‐induced extrapyramidal reactions and of drugs given for their control.British Journal of Clinical Pharmacology, 1976
- 3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrierLife Sciences, 1975
- A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's diseaseJournal of Chronic Diseases, 1972
- Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaBMJ, 1971
- Treatment of Parkinsonism with Laevo-DopaBMJ, 1970
- The mechanism of bradykinesia in parkinsonismNeurology, 1966